Abstract:Background: Sjogren's syndrome (SS) is a chronic inflammatory autoimmune disease mainly characterized by dryness, fatigue, and pain. Current therapies for SS in Western medicine are limited. The purpose of this clinical study was to explore the efficacy and safety of using a traditional Chinese medicine (TCM) formula on patients with primary SS. Methods: We performed a 12-week, randomized, double-blinded, placebo-controlled clinical trial at Chung Shan Medical University Hospital. We included 42 patients with SS between the ages of 20 and 80 years who met the classification criteria of the American and European Consensus Group (AECG). Patients who had other severe systemic manifestations or diseases were excluded from this trial. After screening, patients were randomly assigned to the TCM treatment group or placebo group (ratio of 2:1). We treated the TCM group with 6 g of Gan-Lu-Yin granules after breakfast and 6 g of Jia-Wei-Xiao-Yao-San combined with 1 g of Suan-Zao-Ren-Tang and 1 g of Ye-Jiao-Teng every night after dinner. Patients in the control group were treated with a placebo with the same appearance and flavor but only one-tenth the dosage of that received by the treatment group. The European League Against Rheumatism Sjogren's Syndrome Patient-Reported Index (ESSPRI) was used as the primary endpoint at week 12. Secondary endpoints were the Sjogren's Syndrome Disease Activity Index (SSDAI), physician global assessment (PGA), visual analogue scale (VAS), Multidimensional Fatigue Inventory, Medical Outcomes Survey Short Form-36, and the Pittsburgh Sleep Quality Score (PSQI). Adverse events were also recorded. Results: Of the 42 randomized patients, 28 patients were assigned to the TCM treatment group and 14 patients were assigned to the controlled group. During the study period, 5 patients withdrew from the TCM group and 7 withdrew from the control group. At week 12, the ESSPRI scores of both groups had improved. The ESSPRI score of the treatment group decreased by 0.62 (95% CI P = 0.557) and that of the placebo group decreased by 0.91 ( P = 0.557). However, no significant difference was observed between the two groups. Sleep duration in the PSQI was −0.61, which exhibited an improvement of more than the −0.21 compared with the placebo group ( P = 0.914). Conclusion: At week 12, the ESSPRI scores did not reveal that the use of the TCM formula was efficacious for treating patients with Sjogren's syndrome. However, the PSQI scores indicated that this formula could prolong patient sleep duration. We also found that this formula could decrease the blood pressure of patients.

Current State of TCM Syndrome Differentiation and Treatment for Sjogren′s Disease

Pathogenesis and diagnostic and therapeutic characteristics of Sjogren's syndrome based on TCM theory of five zang-organs

From the transition of classification criteria to view diagnosis and differential diagnosis of Sj(o)gren's syndrome

Advances in the Pathogenesis and Treatment of Primary Sj(o)gren's Syndrome

Syndromes Clinical Literature Study of the Traditional Chinese Medicine to Sjogren's Syndrome

Traditional Chinese medicine for sjögren's syndrome: a national survey of attitudes and perceptions among Chinese patients and rheumatologists

Challenges in Treatment of Primary Sjögren’s Syndrome and Opportunities for Chinese Medicine

Syndrome differentiation in modern research of traditional Chinese medicine

The Immune Factors Involved in the Pathogenesis, Diagnosis, and Treatment of Sjogren's Syndrome

Advances in TCM Syndrome Differentiation Treatment of Myasthenia Gravis

Clinical Observation of Acupuncture and TCM in Treatment of 30 cases Primary Sjogren Syndrome

Traditional Chinese Medicine in Patients With Primary Sjogren's Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Immunobiology of T Cells in Sjögren’s Syndrome

Evolution of Diagnostic Criteria for Sjögren′s Syndrome

Pathogenesis and treatment of Sjogren's syndrome: Review and update

Traditional Chinese Medicine for Sjögren’s Syndrome: a National Survey of Attitudes and Perceptions among Chinese Patients and Rheumatologists

Study on the treatment of systemic lupus erythematosus by Traditional Chinese Medicine

Syndrome Differentiation and Treatment Regularity in Traditional Chinese Medicine for Type 2 Diabetes: A Text Mining Analysis

Chinese traditional medicine literature review of oral sjogren syndrome

A relatively rare traditional Chinese medicine pattern of primary Sjögren syndrome: A case report

Advances in Pathogenesis of Sjögren’s Syndrome